REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Shanghai Rightongene Biotechnology Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanghai Rightongene Biotechnology Co., Ltd. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shanghai Rightongene Biotechnology Co., Ltd. focuses on the R&D, production, sales and testing services of in vitro diagnostic products. The company was founded in 2012 and is headquartered in Shanghai City, China.

Headquarters
Building 3, No. 6055 Jinhai Road, Fengxian District, Shanghai
Shanghai; Shanghai; Postal Code: 201403

Contact Details: Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.

Website: http://www.rightongene.com

Basic Information
Total Employees:
Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.
Registered Capital:
Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.
Incorporation Date:
February 17, 2012
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
18.22%
Purchase this report to view the information.
11.1%
Purchase this report to view the information.
8.82%
Purchase this report to view the information.
3.58%
Purchase this report to view the information.
2.62%
Subsidiaries
Shanghai Ruiangyuntai Biomedical Technology Co., Ltd.
100%
Shanghai Yuanqi Biomedical Technology Co., Ltd.
100%
Suzhou Yuntai Biomedical Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shanghai Rightongene Biotechnology Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
12.84%▲
Total operating revenue
12.25%▲
Operating profit (EBIT)
17.43%▲
EBITDA
-123.36%▼
Net Profit (Loss) for the Period
72.88%▲
Total assets
-3.5%▼
Total equity
-1.53%▼
Operating Profit Margin (ROS)
1.26%▲
Net Profit Margin
7.08%▲
Return on Equity (ROE)
0.4%▲
Debt to Equity Ratio
1.57%▲
Quick Ratio
3.68%▲
Cash Ratio
1.33%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Hubei Biocause Pharmaceutical Co.,Ltd.
 
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
Zhejiang Haisen Pharmaceutical Co., Ltd.
 
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd.
Tibet Duo Rui Pharmaceutical Co., Ltd.
 
Guanhao Biotech Co.,Ltd.
Chengdu Sheng Nuo Biotec Co.,Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo